(Q43690018)

English

Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Y Obase

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Shimoda

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S Tomari

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

K Mitsuta

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

C Fukushima

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Kawano

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Matsuse

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S Kohno

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

43-47

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Leukotrienes as Mediators of Airway Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotrienes are potent constrictors of human bronchi

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of synthetic leukotrienes on tracheal microvascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide clinical experience with the first marketed leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-induced lupus in a child after treatment with zafirlukast (Accolate)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Churg-Strauss syndrome associated with zafirlukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary eosinophilia associated with montelukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotrienes in the pathogenesis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardization of bronchial inhalation challenge procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962321-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62321-6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43690018&oldid=2102601350"